Fresenius Medical Care AG (FMS) Depreciation & Amortization (CF) (2009 - 2025)

Fresenius Medical Care AG's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $434.2 million for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 14.82% year-over-year to $434.2 million; the TTM figure through Mar 2026 stood at $1.3 billion (down 26.7% YoY), while the FY2025 annual figure was $1.7 billion, down 6.25% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $434.2 million, up from $417.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $556.7 million in Q1 2024, with the low at $400.9 million in Q3 2024.
• The 5-year median for Depreciation & Amortization (CF) is $470.2 million (2022), against an average of $466.2 million.
• The sharpest annual moves came in 2021 and 2024: Depreciation & Amortization (CF) declined 27.83% in 2021, then rose 18.42% in 2024.
• Fresenius Medical Care AG's Depreciation & Amortization (CF) stood at $499.9 million in 2021, then advanced by 1.02% to $505.0 million in 2022, then decreased by 9.24% to $458.4 million in 2023, then rose by 11.21% to $509.7 million in 2024, then retreated by 14.82% to $434.2 million in 2025.
• Business Quant data shows FMS's Depreciation & Amortization (CF) at $434.2 million in Q4 2025, $417.7 million in Q3 2025, and $425.6 million in Q2 2025.